[The antioxidant system function of the blood in leukemia patients and its alteration during combined therapy].
Changes observed in functional activity of thiodisulphide antioxidant system (TD AOS) in leukemia patients' blood are shown to depend in intensity and direction on the disease course and efficacy of relevant treatment. TD AOS parameters which reflect body defenses may serve additional criteria in the control of the treatment intensity.
G A
GA
Baskovich
Z S
ZS
Tkhorzhevskaia
A Iu
AIu
Panina
S V
SV
Gritsaev
N N
NN
Kiseleva
I N
IN
Makarova
K M
KM
Abdulkadyrov
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000975:Antioxidants; D003131:Combined Modality Therapy; D006801:Humans; D007938:Leukemia / Q000097:blood* / Q000628:therapy*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy; D008875:Middle Aged; D010288:Parenteral Nutrition; D013438:Sulfhydryl Compounds / Q000097:blood*; D013440:Sulfides / Q000097:blood*
D000975:Antioxidants; D013438:Sulfhydryl Compounds; D013440:Sulfides
Sostoianie antioksidantnoĭ sistemy krovi bol'nykh leĭkozami i ee izmenenie v protsesse kompleksnoĭ terapii.